Mechanistic aspects of chiral discrimination by surface-immobilized α1-acid glycoprotein

Chirality

Volumn 11, Issue 3, 1999, Pages 224-232

  Waters, M See ^a   Sidler, D R ^a   Simon, A J ^a   Middaugh, C R ^a,b   Thompson, R ^a   August, L J ^a,c   Bicker, G ^a   Perpall, H J ^a   Grinberg, N ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

^b UNIVERSITY OF KANSAS   (United States)

^c NORTHROP GRUMMAN CORPORATION   (United States)

Author keywords

AGP; Enantiomeric separation; Fluorescence spectroscopy; Van't Hoff plot

Indexed keywords

L 708738; LEUKOTRIENE RECEPTOR BLOCKING AGENT; MONTELUKAST; OROSOMUCOID; UNCLASSIFIED DRUG;

ARTICLE; CHIRALITY; DRUG DETERMINATION; ENANTIOMER; IMMOBILIZATION; PRIORITY JOURNAL; STEREOCHEMISTRY; STEREOSPECIFICITY;

EID: 0032975769     PISSN: 08990042     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1520-636X(1999)11:3<224::AID-CHIR9>3.0.CO;2-E     Document Type: Article

References (60)

1. Schmid K. The plasma proteins. Vol. 1. Putnam F, editor. New York: Academic Press; 1975. p 183-228.
2. Aubert J, Biserte G, Loucheux-Lefebvre M. Carbohydrate-peptide linkage in glycoproteins. Arch Biochem Biophys 1976;175:410-418.
3. 1-acid glycoprotein, a lipocalin-family member. Protein Seq Data Anal 1993;5:349-355.
4. Aubert J, Loucheux-Lefebvre M. Conformational study of α1-acid glycoprotein. Arch Biochem Biophys 1976;175:400-409.
5. Halsal HB, Kirley TL. Observations on the thermostability of orosomucoid. Biochem Biophys Res Comun 1981;2:761-765.
6. 1-acid glycoprotein (orosomucoid) as determined with fluorescent probes. Biochim Biophys Acta 1986;871:61-71.
7. Jirgensons B. Conformational transitions of non-helical proteins effected by dodecyl sulfate. Biochim Biophys Acta 1976;434:58-68.
8. 1-acid glycoprotein (orosomucoid). J Pharm Pharmacol 1982;34:152-157.
9. 1-acid glycoprotein is compatible with a loosely folded region in its polypeptide chain. Biochemistry 1990;29:8689-8695.
10. Paxton J. Alpha1-acid glycoprotein and binding of basic drugs. Meth and Find Exptl Clin Pharamacol 1983;5:635-648.
11. Borga O, Piafsky K, Nilsen O. Plasma protein binding of basic drugs. Clin Pharmacol Ther 1977;22:539-544.
12. Piafsky K. Disease-induced changes in the plasma binding of basic drugs. Clin Phamacokinet 1980;5:246-262.
13. 1-acid glycoprotein Interaction. Biol Pharm Bull 1993;9:926-929.
14. 1-acid glycoprotein. Focus on a single binding site. In: Tillement J, Lindenlaub E, editors. Protein binding and drug transport. Stuttgart: Schattauer; 1986. p 29-44.
15. 1-acid glycoprotein (orosomucoid). Naunyn-Schmiedeberg's Arch Pharmacol 1983;322:170-173.
16. Rutledge DR, Szlaczky M. The effect of pH on gallopamil protein binding. Pharm Res 1988;9:619-620.
17. 1-acid glycoprotein. Chem Pharm Bull 1990;6:1688-1691.
18. Nyberg G, Martensson E. Binding of thioridazine metabolites to serum proteins, an in vitro study. Nuanyn-Schmiedeberg's Arch Pharmacol 1982;319:189-196.
19. 1-acid glycoprotein. Biochem Pharmacol 1991;3:377-383.
20. 1-acid glycoprotein. J Phys Chem 1993; 97:10857-10861.
21. Oravcova J, Bystricky S, Trnovec T. Different binding of propranolol enantiomers to human alpha-1-acid glycoprotein. Biochem Pharmacol 1989;16:2575-2579.
22. 1-acid glycoprotein: a calorimetric study. J Pharm Pharmacol 1989;41:674-679.
23. 1-acid glycoprotein studied by circular dichroism. Pharm Res 1989;2:156-159.
24. 1-acid glycoprotein (orosomucoid). Biochem J 1993;289: 767-770.
25. Campbell D. Stereoselectivity in clinical pharmacokinetic and drug development. Eur J Drug Metab Pharmacokinet 1990;15:109-125.
26. 1-acid glycoprotein (orosomucoid). J Pharm Pharmacol 1987;39:986-990.
27. Kremer J, Wilting J, Janssen L. Drug binding to human alpha-1-acid glycoprotein in health and disease. Pharmacol Rev 1988;40:1-47.
28. Lunde P, Pike E. Bredesen, inflammation and alpha-1-acid glycoprotein: effect on drug binding. In: Reidenberg M, Erill S, editors. Drug-Protein Binding. New York: Praeger; 1986. p 201-219.
29. Bauman P, Eap C. Therapeutic drug monitoring: role of alpha-1-acid glycoprotein (AGP) binding. In: Sunshine I, editor. Recent Developments in Therapeutic Drug Monitoring and Clinical Toxicology. New York: Marcel Dekker; 1992. p 153-157.
30. 1-acid glycoprotein - genetic, biochemistry, physiological functions and pharmacology. New York; Alan R. Liss. 1989.
31. 1-acid glycoprotein as the chiral stationary phase. J Chromatogr 1983;269:71-80.
32. 1-acid glycoprotein bonded stationary phase. J Liq Chromatogr 1986; 9:641-666.
33. Haupt D, Pettersson C, Westerlund D. Optimization of the chiral resolution of four hydrophobic amines on chiral-AGP by a central composite face design (CCF). Fresenius' J Anal Chem 1995;352:705-711.
34. Li F, Cooper S, Cote M, Ayotte C. Determination of the enantiomers of bunolol in human urine by high-performance liquid chromatography on a chiral AGP stationary phase and identification of their metabolites by gas chromatography-mass spectrometry. J Chromatogr B 1994;660: 327-339.
35. 1-acid glycoprotein with triethylamine significantly improves the detection sensitivity of an enantiomeric leukotriene antagonist. J Liq Chromatogr 1994;4:761-772.
36. 1-acid glycoprotein as the chiral complexing agent in the mobile phase. J Chromatogr 1984;316:537-546.
37. Enquist M, Hermansson J. Separation of the enantiomers of β-receptor blocking agents and other cationic drugs using a CHIRAL-AGP® column. J Chromatogr 1990;519:285-298.
38. 1-acid glycoprotein. Trends Anal Chem 1989;8:251-259.
39. Karlsson A, Pettersson K, Hernqvist K. Resolution and determination of enantiomeric purity of the enantiomers felodipine using chiral-AGP® as a stationary phase. Chirality 1995;7:147-153.
40. 1-acid glycoprotein column. J Chromatogr A 1995;694:57-69.
41. Narayanan S. Immobilized proteins as chromatographic supports for chiral resolution. J Pharm Biomed Anal 1992;10:251-262.
42. Fitos I, Visy J, Simonyi M, Hermansson J. Separation of enantiomers of benzodiazepines on the chiral-AGP column. J Chromatogr A 1995;709: 265-273.
43. 1-acid glycoprotein and human serum albumin columns. J Chromatogr 1992;609:163-171.
44. Hermansson J, Hermansson I. Dynamic modification of the chiral bonding properties of a CHIRAL-AGP column by organic and inorganic additives. J Chromatogr A 1994;666:181-191.
45. 1-acid glycoprotein bonded stationary phase (Enantiopac®). II. Influence of mobile phase additives and pH on chiral resolution and retention. J Chromatogr 1986;365:73-88.
46. 1-acid glycoprotein column. Chromatographia 1987;24:520-526.
47. 1-acid glycoprotein column (Enantiopac®). J Liq Chromatogr 1986;9:621-639.
48. Williams R, Edwards J, Potter M. Retention characteristics of protein-based chiral HPLC columns. J Liq Chromatogr 1993;16:171-196.
49. 1-acid glycoprotein. In: Zief M, Crane L, editors. Chromatographic Chiral Separations. New York and Basel: Marcel Dekker; 1988. p 245-281.
50. Hermansson J, Schill G. In: Brown P, Hartwick R, editors. High Performance Liquid Chromatography. New York: John Wiley & Sons; 1988. p 337-374.
51. 4 receptor antagonist devoid of peroxisomal enzyme induction. Bioorg Med Chem Lett 1995;5:283-288.
52. Jones T, Labelle M, Belley M, Champion E, Charette L, Evans J, Ford-Hutchinson A, Gauthier J, Lord A, Masson P, McAuliffe M, McFarlane C, Metters K, Pickett C, Piechuta H, Rochette C, Roger I, Sawyer N, Young R, Zamboni R, Abraham W. Pharmacology of montelukast sodium (Singulair™), a potent and selective leukotriene D4 receptor antagonist. Can J Physiol Pharmacol 1995;73:191-201.
53. 4 antagonist L-708,738. Tetrahedron Asymmetry 1997;8:161-168.
54. Chong K, Loughlin T, Moeder C, Perpall HJ, Thompson R, Grinberg N, Smith GB, Bicker G. Drug substance manufacture process control: application of flow injection analysis and HPLC for monitoring an enantiospecific synthesis. J Pharm Biomed Anal 1996;15:111-121.
55. Moeder C, Grinberg N, Perpall HJ, Bicker G, Tway P. Flow injection determination of Triton-X-100 with on-line solid-phase extraction. Analyst 1992;117:767-771.
56. Smith PH, Morris DE, Ryan RR. ACS abstract, 1991.
57. Choo LT, Carr PW. Extra-thermodynamic relationship between the slopes and intercepts of plots of ln k′ vs. mobile phase composition in reversed-phase chromatography. J Chromatogr 1993;656:521-535.
58. Kuhn R, Hoffstetter-Kuhn S. Capillary electrophoresis. Berlin Heidelberg: Springer-Verlag; 1993. p 88.
59. Haidacher D, Vailaya A, Horvath C. Temperature effects in hydrophobic interaction chromatography. Proc Natl Acad Sci 1996;93:2290-2295.
60. Cantor CR, Schimmel PR. Biophysical Chemistry. New York: W.H. Freeman and Company; 1980. p 443.